Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players√Ę‚ā¨‚ĄĘ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Request Free Sample
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Speak to Analyst

BRICS Diabetes Treatment And Prevention Market Research Report Information, By Type (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), By Treatment (Medication, Gene Therapy, Others), By Devices (Blood Glucose Meters And Strips., Continuous Glucose Monitors (Cgms), Injection Pens, Insulin Pump, Others), By End Users (Hospitals, Clinics, Pharmaceutical Companies And Others) - Forecast To 2030


ID: MRFR/Pharma/0815-HCR | 80 Pages | Author: Kinjoll Dey| April 2024

BRICS Diabetes Treatment And Prevention Market Overview


The BRICS Diabetes Treatment and Prevention Market is projected to reach USD 12,383.6 Million by 2030 at 13.4% CAGR during the forecast period 2022-2030


Diabetes is a chronic disease characterized by elevated levels of blood glucose which leads to serious damage to the heart, eyes, kidneys, blood vessels and nerves. The most common of diabetes is type 2 diabetes which occurs when the body becomes resistant to insulin or doesn't make enough insulin. In the past three decades the prevalence of type 2 diabetes has risen dramatically in countries of all income levels. Type 1 diabetes, once known as juvenile diabetes or insulin-dependent diabetes, is a chronic condition in which the pancreas produces little or no insulin by itself. The market of diabetes treatment and prevention is increasing due to an increase in the prevalence of diabetes, changing lifestyle and increasing use of insulin for the treatment of diabetes. Increase awareness regarding prevention and treatment of diabetes favor the growth of this market.    Study objectives:



  • Main objective of this research is to provide information about diabetes treatment and prevention market, types of diabetes, treatment and end users.

  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the diabetes treatment and prevention market.

  • To provide insights about factors affecting the market growth.

  • To analyze the diabetes treatment and prevention market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.

  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main countries- Brazil, Russia, India, China and South Africa.

  • To provide country level analysis of the market with respect to the current market size and future prospective.

  • To provide country level analysis of the market for segments by types of diabetes, treatment, end users and its sub-segments.

  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.

  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the BRICS diabetes treatment and prevention market.


Figure 1: Global Diabetes Treatment and Prevention Market, by type: BRIC Diabetes Treatment Prevention Market


Key Players: Abbott Laboratories (U.S), Bayer AG (Germany), Eli Lily & Company (U.S), Medtronic (U.S), AstraZeneca Plc. (U.K), Lifescan (U.S), Terumo Medical Corporation (Japan) and Roche Holding AG (Switzerland).


BRICS Diabetes Treatment And Prevention Market Segment Insights


BRICS Diabetes Treatment And Prevention Type Insights


on the basis of type of diabetes which includes type 1 diabetes, type 2 diabetes and gestational diabetes. 


BRICS Diabetes Treatment And Prevention Treatment Insights


On the basis of treatment the market is segmented into medication, gene therapy


BRICS Diabetes Treatment And Prevention Devices Insights


On the basis of devices, Blood Glucose Meters and Strips, Continuous Glucose Monitors (CGMs), Injection Pens, Insulin Pump, others. 


BRICS Diabetes Treatment And Prevention End Users Insights


On the basis of end users the market is segmented into hospitals, clinics, pharmaceutical companies and other end users.


Figure 2: Research Methodology BRIC Diabetes Treatment Prevention Market-


BRICS Diabetes Treatment And Prevention Regional Insights


Diabetes treatment and prevention market consists of four regions namely Brazil, Russia, India, China and South Africa. China is the largest market. India is second largest and fastest growing market. The market shows steady growth in Brazil and Russia.


The report for diabetes treatment and prevention market of Market Research Future comprises of extensive primary research along with detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value & volume, technological advancement, macro economical, and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.


 Intended Audience




  • Diabetes drugs manufacturers




  • Diabetes drug suppliers




  • Contract Research Organizations (CROs)




  • Research and Development (R&D) Companies




  • Academic Medical Institutes and Universities



Report Attribute/Metric Details
  Market Size   USD 12,383.6 million
  CAGR   13.4%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Type, Devices, Treatment and End User
  Geographies Covered   America, Europe, Asia Pacific and Middle East & Africa
  Key Vendors Abbott Laboratories (U.S), Bayer AG (Germany), Eli Lily & Company (U.S), Medtronic (U.S), AstraZeneca Plc. (U.K), Lifescan (U.S), Terumo Medical Corporation (Japan) and Roche Holding AG (Switzerland).
  Key Market Opportunities The prevalence of type 2 diabetes has risen dramatically in countries
  Key Market Drivers Diabetes treatment and prevention is increasing due to an increase in the prevalence of diabetes


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Request Free Sample
Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Ask for Customization